ADIPOQ and breast carcinoma: Macis et al. reported that circulating adiponectin is associated with reduced breast cancer risk in both premenopausal women (summary RR = 0.72 (95% CI, 0.30–1.72)) and postmenopausal women (summary RR = 0.80 (0.63–1.01)) [106], though findings reported by others are mixed (i.e., [108,109,110]).